Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.

× No keyword cloud information.

16 in total

1. Internalization and down-regulation of the prostacyclin receptor in human platelets.

Authors: S Giovanazzi; M R Accomazzo; O Letari; D Oliva; S Nicosia
Journal: Biochem J Date: 1997-07-01 Impact factor: 3.857

2. Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.

Authors: P Golino; J T Willerson
Journal: Tex Heart Inst J Date: 1991

Review 3. New Concepts and Mechanisms of Platelet Activation Signaling.

Authors: Brian Estevez; Xiaoping Du
Journal: Physiology (Bethesda) Date: 2017-03

4. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.

Authors: K Schrör; P Rösen
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1979-01 Impact factor: 3.000

5. Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis.

Authors: Roberto Gabriel Pozner; Soledad Negrotto; Lina Paola D'Atri; Mónica Lidia Kotler; María Angela Lazzari; Ricardo Martin Gomez; Mirta Schattner
Journal: Br J Pharmacol Date: 2005-06 Impact factor: 8.739

6. Large effects of preparative techniques on lymphocyte cyclic AMP content.

Authors: J P Moore; G A Smith; T R Hesketh; J C Metcalfe
Journal: Biochem J Date: 1983-10-15 Impact factor: 3.857

Review 7. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors: S Moncada
Journal: Br J Pharmacol Date: 1982-05 Impact factor: 8.739

8. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.

Authors: H Amirrasooli; S Mac Neil; S Tomlinson
Journal: Br J Pharmacol Date: 1981-07 Impact factor: 8.739

9. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Authors: G C Le Breton; D L Venton; S E Enke; P V Halushka
Journal: Proc Natl Acad Sci U S A Date: 1979-08 Impact factor: 11.205

10. Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors: T Fujimoto; S Ohara; J Hawiger
Journal: J Clin Invest Date: 1982-06 Impact factor: 14.808